Investing In Gilead Sciences, Inc (NASDAQ: GILD): Why Should You?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NASDAQ and operates within the Drug Manufacturers – General industry segment. The current market capitalization of Gilead Sciences, Inc is $117.24B. A total of 22.53 million shares were traded on the day, compared to an average of 6.73M shares.

In the most recent transaction, GILEAD SCIENCES, INC. bought 1,759,978 shares of GILD for 1.04 per share on Dec 18 ’24. After the transaction, the 10% Owner now owns 9,105,451 company shares. In a previous transaction on Dec 16 ’24, Dickinson Andrew D sold 8,500 shares at 91.96 per share. GILD shares that Chief Financial Officer owns now total 132,373.

Among the insiders who bought shares, ANDREW DICKINSON acquired of 8,500 shares on Dec 16 ’24 at a per-share price of $91.96. In another insider transaction, Dickinson Andrew D sold 248,645 shares at $92.76 per share on Nov 29 ’24. Company shares held by the Chief Financial Officer now total 138,919.

Dividend

The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Gilead Sciences, Inc pays an annual dividend of $3.08, resulting in a dividend yield of 3.33%, and it has a price to earnings (P/E) ratio of 1043.63. GILD’s most recent ex-dividend date was 3.15% when it declared a $0.77 quarterly dividend that was paid in cash on 12/13/2024. Previously, the company paid the dividend on 9/13/2024 with an ex-dividend date of 4.18%. The GILD stock dividend was $0.77 per share in cash.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, GILD has a high of $98.90 and a low of $62.07.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. GILD’s latest balance sheet shows that the firm has $6.52B in Cash & Short Term Investments as of fiscal 2021. There were $26.70B in debt and $11.61B in liabilities at the time. Its Book Value Per Share was $14.83, while its Total Shareholder’s Equity was $21.06B.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GILD is Buy with a score of 4.10.

Most Popular

Related Posts